YouTube Facebook LinkedIn Google+ Twitter Xingrss  


Competing Drug Companies May Combine Late-Stage Trials of Drug Candidates



August 20, 2013 | TranCelerate Biopharma reports that it has signed agreements facilitating head to head drug trials. The agreements allow drug makers to buy a competitor’s product for use in comparative clinical trials. The agreements are the first in a move toward more open drug development, TranCelerate says. Boston Business Journal
Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Jay Mulhern, (781) 972-1359, jmulhern@healthtech.com.